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Aims: To estimate the prevalence of urinary incontinence (UI) and to assess its risk factors among postmenopausal
Estonian women.
Methods: In 2004, 1363 women participating in the Estonian Postmenopausal Hormone Therapy Trial were asked
at the closure visit to the trial physician about symptoms of UI. The type of incontinence was assessed with the
help of a questionnaire, based on recommendations from the working group set up by the Finnish Gynaecological
Association. Frequency characteristics were analysed by descriptive statistics. Risk factors were examined using
logistic regression.
Results: Mean age of study women was 53.3 years (min = 48, max = 67; SD 4.0). The prevalence of UI was 18.12%
(95% CI: 16.07 − 20.17). Stress incontinence was diagnosed in 78.83% (95% CI: 73.32 − 84.33) and urge or mixed
incontinence in 21.17% (95% CI: 15.67 − 26.68) of women who reported incontinence. Prevalence of UI slightly
increased with age. Women who used hormone therapy (HT) (OR 1.67; 95% CI: 1.17 − 2.39), had had hysterectomy
(1.73, 95% CI: 1.06 − 2.83), and those with secondary education (OR 1.87, 95% CI: 1.23 − 2.82) or basic education
(OR 3.29, 95% CI: 1.80 − 6.02) had a higher risk for UI. Parity, having a BMI over 30 kg/m2, being a smoker or a
former smoker, having diabetes and being physically or sexually active, tended to increase the risk of UI.
Conclusions: About one in five postmenopausal women in Estonia reported to have UI. Risk factors linked with UI,
its prevalence in other age groups and the impact of UI on quality of life deserve more research.
Trial registration: Number: ISRCTN35338757
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Urinary incontinence (UI) has been defined by the Inter-
national Continence Society as: “the complaint of any
involuntary leakage of urine” or as: “urine leakage seen
during examination” (Abrams et al. 2002). Urogenital
problems in the adult female population are common and
have a significant impact on the physical, psychological
and socio-economic aspects of life (Botlero et al. 2008). UI
is one of the most significant urinary problems.
Depending its pathophysiologic process, UI is categorised
into stress urinary incontinence (SUI), urge incontinence
(sensory and motor) and mixed incontinence (Abrams
et al. 2002). The differential diagnosis is important as it* Correspondence: piret.veerus@tai.ee
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in any medium, provided the original work is pdetermines treatment and prognosis. A detailed under-
standing of the prevalence of UI in women is an essential
step in reducing the huge impact of this condition.
The prevalence of urinary incontinence is estimated to
be in the range of 12 − 69%, although estimates vary
greatly in different countries and depend upon the age
of the study group (Botlero et al. 2008; Andersson et al.
2004; Correia et al. 2009; Hunskaar et al. 2004; Irwin
et al. 2006; Lasserre et al. 2009; Simeonova et al. 1999;
Thom 1998; Cerruto et al. 2013). Various factors can
cause pathophysiological changes in the muscular and
fascial structures of the pelvic floor and lead to pelvic
support defects and possible pelvic floor dysfunction.
One of the main risk factors for developing urinary
incontinence is believed to be pregnancy, childbirth and
vaginal delivery resulting in injury to structures within
the pelvic floor (Dolan & Hilton 2010; Serati et al. 2008).open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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and incontinence, however, is not finally understood.
Some population–based studies show an association
between parity and urinary incontinence, others not.
The prevalence of SUI has been reported to increase at
menopause and at menopausal age, and is more common
in women than men, implicating menopause (Correia
et al. 2009; Irwin et al. 2006; Iosif et al. 1981; Tinelli et al.
2010). In Estonia the average age at menopause is
50.3 years (Kirss et al. 2006).
Most epidemiological studies have shown clear associ-
ation between urinary incontinence and obesity and
certain medical comorbidities, particularly diabetes and
stroke (Correia et al. 2009; Irwin et al. 2006; Dolan &
Hilton 2010; Menezes et al. 2010). The association
between incontinence and other factors/conditions is
less clear. There is conflicting data about the potential
roles of education, hysterectomy, constipation, and smoking
in the development of incontinence (Correia et al. 2009;
Irwin et al. 2006; Serati et al. 2008; Menezes et al. 2010;
Rortveit et al. 2001; Waetjen et al. 2007).
The aim of this study was to estimate the prevalence
(total and by type) and risk factors of UI in the Estonian
postmenopausal female population. There are no earlier
data available about the prevalence of urinary incontin-
ence in Estonia.
Methods
We used the data from Estonian Postmenopausal Hormone
Therapy Trial. The trial was a long–term preventive trial of
hormone therapy among healthy postmenopausal women
during 1999–2004. Women were recruited into the trial by
the means of a questionnaire which was mailed to 39713
postmenopausal women aged 50 to 64 and living in Tallinn
(the capital of Estonia), Tartu, and in two counties
surrounding these towns together with an information
leaflet describing the trial and asking about their health
status and willingness to participate in a postmenopausal
hormone therapy trial. Potentially eligible 4295 women
were randomised into four trial arms: 1) blind hormone
therapy arm, 2) blind placebo arm, 3) non-blind hormone
therapy arm, 4) non-treatment arm. Randomisation oc-
curred before mailing the invitation to the recruitment
visit in order to study the impact of blinding on recruit-
ment. Randomised women were mailed an invitation to
the recruitment visit, indicating whether they had been
randomised to the blind or the non-blind sub-trial. As a
result, altogether 1823 participants were recruited at three
clinical centers between January 1999 and December
2001. Details of the trial design, randomisation, eligibility
criteria, recruitment, and clinical follow-up of participants
are described elsewhere (Veerus et al. 2006). Trial treat-
ment was gradually stopped by May 2004, and closure
visits took place from January 2004 to May 2004.The mean duration of trial treatment was 3.6 years.
Participants were followed by annual medical check-ups,
annually mailed questionnaires and annual linkages to
health registries. The trial design was approved by the
Tallinn Medical Research Ethics Committee, Estonia and by
the Ethics Committee of the University Clinic of Tampere,
Finland. All participants signed written informed consent.
The main aims of the EPHT Trial were to study the
effect of postmenopausal hormone therapy on the risk
of cancer, cardiovascular diseases and bone fractures and
the related use of health services, and quality of life.
Approximately half of the trial women in the HT arms
took more than 80% of allocated trial treatment during
the last trial year. (Vorobjov et al. 2005) We analysed
the prevalence of UI among postmenopausal women
using the data from the closure visit of the EPHT Trial.
Participants of the current study were all 1363 women
(74.8% of trial participants) who attended the closure
visit to the trial doctor in 2004 when trial treatment was
stopped. During the interview with the trial participants,
the trial physicians filled in a questionnaire which in-
cluded questions about health outcomes (whether the
woman had been diagnosed with cancer, thrombosis,
myocardial infarction, stroke, or diabetes), gynaecological
operations, and a question asking if they had urinary
leakage of any type. The 247 (18.12%) women who said
that they had urinary leakage of any type had to answer
ten more questions to specify the type of incontinence.
The questionnaire (Table 1) was based on recommen-
dations from the working group set up by the Finnish
Gynaecological Association (Mäkinen et al. 1992). If the
score was less than or equal to 8, stress-incontinence
was diagnosed. If the score was above 8, urge or mixed
incontinence was diagnosed.
Quality of life was not assessed at the closure visit. Infor-
mation about physical activity in the preceding 3 months,
sexual intercourse in preceding 12 months, smoking, and
other background information was obtained from the last
annual questionnaire, sent by mail. The response rate to
the final questionnaire was 81% (Veerus et al. 2008).
Data analysis
Frequency characteristics were analysed by descriptive sta-
tistics. Risk factors were estimated by calculating crude
and adjusted odds ratios (by means of logistic regression).
A two-sided p value of 0.05 was considered to indicate
statistical significance. Missing values in the UI question-
naire were imputed by multiple imputation using binary
and ordered logistic regression. The Stata 9.2 software was
used.
Results
The mean age of women attending the closure visit and
responding to the questionnaire was 53.3 years (min = 48,
Table 1 Female urinary incontinence score questionnaire
Question Score
0 1 2
1. Do you feel the urge to urinate before urinary incontinence occurs? No Slight Strong
2. Does urinary incontinence occur in situations that don’t involve physical exercise? No Yes
3. Does urinary incontinence occur during physical exercise? At once In a moment
4. What is the amount of leakage urine? Just drops Little A lot
5. Are you able to intentionally stop urinating? Yes No
6. Does pressure and moving around cause the urge to urinate? No Slight Strong
7. Is there any urine left in the bladder? No Sometimes Frequently
8. How many times do you urinate during the day? 5-7 8-10 11 or more
9. How many times do you urinate during the night? 0-1 2-3 4 or more
10. Have you suffered from urinary tract infection during the last two years? No 1-2 times Over 2 times
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group are presented in Table 2. About 40% of women
were aged 62–66 years, forming the biggest age group,
and women aged 57–61 years constituted one third of the
respondents. Regarding place of residence, three quarters
of women lived in the city. More than half of the respon-
dents had secondary education, and over one third of
women had higher education.
The mean number of deliveries per woman was 1.8
(min = 0, max = 7; SD = 0.96). Almost half of women
had had two deliveries and one fourth had had one de-
livery. The data revealed that 16.3% of women had had
three or more deliveries and 9.8% of participants were
nulliparous. A majority of participants (72.1%) were
non-smokers, 13.4% were smokers and 14.5% were pre-
vious smokers. Around one fifth of the participants were
obese with a body mass index (BMI) 30 kg/m2 or over
and 41.9% of women had BMI of 25–29 kg/m2. About
three percent of women were diabetic and around one
in eight had had a hysterectomy. Nearly 40% of women
were using HT, about a quarter reported to be physically
active and about two in five having had intercourse
within the preceding 12 months.
Data about the prevalence of urinary incontinence are
presented in Table 3. The prevalence of urinary incon-
tinence was 18.12% (95% CI: 16.07 − 20.17). The type of
incontinence was estimated among 222 women of 247
who had reported UI. Among them, 150 had specified
the type of incontinence. For the rest 97 women who
had not answered some of the questionnaire questions,
imputation was used to impute the missing values in the
questionnaire (one answer was missing in 44 question-
naires, two in 20, three in seven, five in one, and for 25
respondents who did not fill in the questionnaire no
imputation was used). After multiple imputation, the
analysis showed stress incontinence in 78.83% (95% CI:
73.32 − 84.33) of the respondents and urge or mixed in-
continence in 21.17% (95% CI: 15.67 − 26.68).Table 4 presents the analysis of risk factors for UI. Risk
of UI increased slightly with age but it was not statisti-
cally significant. Less educated women had a higher risk
for UI. When women with basic education were com-
pared with the ones with higher education, the adjusted
risk for UI was about three times higher. HT use nearly
doubled the risk of UI. Parity was also a risk factor, with
women who had ever given birth tending to have a
higher risk for UI when compared to women with no
deliveries. Having a BMI over 30 kg/m2, being a smoker,
being physically and sexually active tended to increase
the risk of UI, although no statistically significant differ-
ences were found . A similar association, although with a
higher risk estimate was seen for the association be-
tween diabetes and UI. Hysterectomy increased the
probability of UI.
Discussion
The current study serves as the first step to quantify the
disease burden caused by urinary incontinence in Estonia
and to look into its risk factors. To our knowledge there
have been no previous studies on prevalence and risk fac-
tors of UI among Estonian women. We found the preva-
lence of UI to be 18.12% among women aged 52–69 years.
The prevalence of UI reported by us is significantly lower
than rates reported in other studies among similar age
groups (Botlero et al. 2008; Menezes et al. 2010; Waetjen
et al. 2007). Comparing our results with population based
studies, the prevalence of UI among women was remark-
ably lower than in France, Germany and UK (all around
40%), or in Spain and Portugal (23%) (Correia et al. 2009;
Irwin et al. 2006). The EPIC study found a global preva-
lence of 18% in women aged above 17 years in Sweden,
Italy, Canada, Germany and UK (Correia et al. 2009; Irwin
et al. 2006). Swedish longitudinal data suggested that the
prevalence of UI was approximately 20% and it did not
differ significantly in women aged more than 19 years in
1991 and 2007 (Wennberg et al. 2009).
















































Table 2 Main background characteristics of the study
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69 years show an even lower prevalence than among
younger women in other counties. Only Andersson et al.
in their study reported similar results to our study (19%)
(Andersson et al. 2004). Partly, the UI prevalence in our
study may be lower because the information was col-
lected by a face-to-face interview in the physician’s of-
fice. Personal interviews are known to contribute to
underreporting of sensitive issues, such as UI (Rhodes
et al. 1995), and if it is not possible to carry out a clinical
assessment of urinary dysfunctions, telephone interviews
are preferred to mailed questionnaires to improve the
completeness and accuracy of the data (Feveile et al.
2007). HT increased the risk of UI in our study, as also
reported from the Nurses’ Health Study II study
(Townsend et al. 2009) and Women’s Health Initiative
trial (Hendrix et al. 2005). The prevalence of the UI in
our study increased with age and was associated with
low educational level, also shown in other studies
(Hannestad et al. 2003; Danforth et al. 2006).
A significant association between parity and urinary
incontinence has been reported earlier (Rortveit et al.
2001). Most women give birth in their twenties, but they
complain with UI several years after delivery and preva-
lence of UI peaks in the middle-aged women (Danforth
et al. 2006). An association is reported in the literature
also between the number of the deliveries and UI
(Hannestad et al. 2003). In our study we did not find
that association to be significant, although the risk of UI
was increased among women who had ever given birth.Table 3 Prevalence and types of urinary incontinence in
the study group
Number Proportion 95% CI
Incontinence
No 1101
Yes 247 18.12 16.07 − 20.17
Missing 15
Type of incontinence
Stress 175* 78.83 73.32 − 84.33
Urge/mixed 47* 21.17 15.67 − 26.68
Missing 25
*Calculated among subjects who had either completely or partly filled in the
questionnaire (n = 222).
Table 4 Association of different background factors with
urinary incontinence
Variable Odds ratio (OR)
Crude 95% CI Adjusted* 95% CI
Age group, yrs
52-56 1 1
57-61 1.27 0.77–2.10 1.29 0.68–2.46
62–66 1.45 0.89–2.37 1.69 0.89–3.20
67–69 1.69 0.97–2.95 1.72 0.83–3.56
Education
Higher 1 1
Secondary 1.39 1.01–1.91 1.87 1.23–2.82
Basic (8–9) 2.41 1.54–3.76 3.29 1.80–6.02
Parity
0 1 1
1 1.82 0.96–3.46 1.87 0.88–3.98
2 1.99 1.08–3.65 1.79 0.88–3.68
3 or more 2.33 1.20–4.53 1.72 0.77–3.83
Smoking
No 1 1
Yes 0.87 0.57–1.34 1.09 0.61–1.97
Previous 1.23 0.84–1.79 1.23 0.75–2.02
BMI, kg/m2
<25 1 1
25–29 1.14 0.82–1.59 0.99 0.66–1.48
> = 30 1.83 1.27–2.63 1.05 0.65–1.72
Diabetes
No 1 1
Yes 1.96 0.89–4.32 2.24 0.94–5.32
Hysterectomy
No 1 1
Yes 1.60 1.09–2.35 1.73 1.06–2.83
HT use
No 1 1
Yes 1.17 0.88–1.54 1.67 1.17–2.39
Physical activity
No 1 1
Yes 0.98 0.71–1.35 1.09 0.74–1.60
Sexual activity
No 1 1
Yes 1.15 0.85–1.56 1.28 0.89–1.83
*adjusted for all other factors presented in the table.
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as obesity and smoking are associated with UI (Feveile
et al. 2007). In our study, having a BMI over 30 kg/m2
and smoking tended to increase the risk of UI, although
did not yield statistical difference, maybe because of a
small number of patients. The risk of UI was also non-
significantly higher among physically and sexually activewomen, a trend which could be explained by the fact
that high-impact physical activities, whether recreational
or occupational, can cause increased pressure on the
bladder.
Hysterectomy is considered the starting point of pelvic
floor symptoms, such as UI, constipation and sexual
disturbances. Our study, similar to other retrospective
and cross-sectional studies, reports a promotive effect of
hysterectomy on UI. However, it is questionable whether
there is a causal relationship because such an effect was
not found in several prospective controlled studies
(Gustafsson et al. 2006; Engh et al. 2006).
Diabetes mellitus, a metabolic disorder caused by an
absolute or relative deficiency of insulin, is a debilitating
and costly disease with multiple serious complications.
A common complication of diabetes mellitus is diabetic
bladder dysfunction which includes time dependent mani-
festations of storage and emptying problems (Daneshgari
et al. 2009), it may also lead to UI. In our study we found
a weak correlation, but the number of women with
diabetes was very low and thus we can not make any
conclusions.
There were a few limitations to our study. First of all,
the study design that we used for this study was not suit-
able for establishing causality between risk factors and
outcome. Secondly, there were some issues regarding
representativeness of the study sample that need atten-
tion. Since Estonia has a relatively small population (1.3
million), the sample size in our study (n = 1363) was
optimal. With regard to composition of the general
Estonian female population of the respective age, the
trial participants in our study were slightly more
educated and urban than the general female population,
and age groups 52–56 and 67–69 in the study were less
representative of the general population. Also, the use of
HT was higher among the trial participants than among
the general population. These deviances from the general
population composition, although statistically not signifi-
cant, could have biased the results concerning prevalence
of UI. For the analysis of risk factors for UI, adjustment
was used to control for these deviances. Thirdly, the
questionnaire used for the initial assessment of UI may
not have been optimal. While concluding the trial in 2004,
UI had not been studied in Estonia and there was no vali-
dated questionnaire in the Estonian language. Therefore, a
questionnaire set up by the Finnish Gynaecological Asso-
ciation was adopted. In the future, a validated question-
naire would be preferable.
In addition to the limitations mentioned above, the
study participants were all postmenopausal, which does
not allow analysing the prevalence of UI in other age
groups. Also, quality of life was measured only during
the first trial years, but not at closure visit, which does
not for an analysis of the effect of UI on womens’ life
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participants was not available, it was not included in the
analysis. Still, the impact of physical activity, sexual ac-
tivity, and HT use on UI was analysed together with
other background factors. Prevalence of UI was analysed
among 1348 women, and the type of UI was calculated
among 222 of women among those 247 who reported to
have it. Imputation was used to substitute the missing
data in the UI questionnaire for 97 women who reported
to have UI, but did not respond to all survey questions.
For the 25 women who had not responded to survey
questions, no imputation could be used.
As a conclusion, there is a need in Estonia for a
population-based longitudinal study to better ascertain
the risk factors of urinary incontinence, quantify the
burden of the problem in different age groups, as well
as estimate the impact of UI on quality of life. The
impact of modifiable risk factors for UI, e.g., smoking,
BMI, hysterectomies and physical training, deserves
additional research.
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